{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:18:53Z","timestamp":1772119133873,"version":"3.50.1"},"reference-count":114,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s00011-018-1190-3","type":"journal-article","created":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T08:28:07Z","timestamp":1538382487000},"page":"47-57","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Pre-eclampsia: the role of highly active antiretroviral therapy and immune markers"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7769-4528","authenticated-orcid":false,"given":"Wendy N.","family":"Phoswa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thajasvarie","family":"Naicker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veron","family":"Ramsuran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jagidesa","family":"Moodley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,1]]},"reference":[{"key":"1190_CR1","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/aji.12393","volume":"74","author":"AI Loewendorf","year":"2015","unstructured":"Loewendorf AI, Nguyen TA, Yesayan MN, Kahn DA. Preeclampsia is characterized by fetal NK cell activation and a reduction in regulatory T cells. Am J Reprod Immunol. 2015;74:258\u201367.","journal-title":"Am J Reprod Immunol"},{"key":"1190_CR2","first-page":"24","volume":"7","author":"KE Duhig","year":"2015","unstructured":"Duhig KE, Shennan AH. Recent advances in the diagnosis and management of pre-eclampsia. F1000prime Rep. 2015;7:24.","journal-title":"F1000prime Rep"},{"key":"1190_CR3","doi-asserted-by":"publisher","first-page":"605","DOI":"10.2471\/BLT.13.127464","volume":"92","author":"S Saleem","year":"2014","unstructured":"Saleem S, McClure EM, Goudar SS, Patel A, Esamai F, Garces A, et al. A prospective study of maternal, fetal and neonatal deaths in low-and middle-income countries. Bull World Health Organ. 2014;92:605\u201312.","journal-title":"Bull World Health Organ"},{"key":"1190_CR4","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S0140-6736(05)17987-2","volume":"365","author":"B Sibai","year":"2005","unstructured":"Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. The Lancet. 2005;365:785\u201399.","journal-title":"The Lancet"},{"key":"1190_CR5","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0140-6736(10)60279-6","volume":"376","author":"EA Steegers","year":"2010","unstructured":"Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. The Lancet. 2010;376:631\u201344.","journal-title":"The Lancet"},{"key":"1190_CR6","first-page":"7","volume":"8","author":"FA English","year":"2015","unstructured":"English FA, Kenny LC, McCarthy FP. Risk factors and effective management of preeclampsia. Integr Blood Press Control. 2015;8:7.","journal-title":"Integr Blood Press Control"},{"key":"1190_CR7","first-page":"24","volume":"72","author":"LA Magee","year":"2018","unstructured":"Magee LA, Kenny L, Karumanchi SA, McCarthy F, Saito S, Hall DR, et al. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis and management recommendations for international practice 2018. Pregnancy Hypertens. 2018;72:24\u201343.","journal-title":"Pregnancy Hypertens"},{"key":"1190_CR8","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/nrneph.2014.102","volume":"10","author":"T Chaiworapongsa","year":"2014","unstructured":"Chaiworapongsa T, Chaemsaithong P, Yeo L, Romero R. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol. 2014;10:466.","journal-title":"Nat Rev Nephrol"},{"key":"1190_CR9","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.ajog.2013.08.019","volume":"209","author":"S Lisonkova","year":"2013","unstructured":"Lisonkova S, Joseph K. Incidence of preeclampsia: risk factors and outcomes associated with early-versus late-onset disease. Am J Obstet Gynecol. 2013;209:544 (e1\u2013e12).","journal-title":"Am J Obstet Gynecol"},{"key":"1190_CR10","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/AOG.0000000000000472","volume":"124","author":"S Lisonkova","year":"2014","unstructured":"Lisonkova S, Sabr Y, Mayer C, Young C, Skoll A, Joseph K. Maternal morbidity associated with early-onset and late-onset preeclampsia. Obstet Gynecol. 2014;124:771\u201381.","journal-title":"Obstet Gynecol"},{"key":"1190_CR11","doi-asserted-by":"publisher","first-page":"586578","DOI":"10.1155\/2012\/586578","volume":"2012","author":"E Eiland","year":"2012","unstructured":"Eiland E, Nzerue C, Faulkner M. Preeclampsia 2012. J Pregnancy. 2012;2012:586578. https:\/\/doi.org\/10.1155\/2012\/586578 .","journal-title":"J Pregnancy."},{"key":"1190_CR12","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1136\/bmj.38380.674340.E0","volume":"330","author":"K Duckitt","year":"2005","unstructured":"Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ. 2005;330:565.","journal-title":"BMJ"},{"key":"1190_CR13","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/S0002-9378(98)70160-7","volume":"179","author":"GA Dekker","year":"1998","unstructured":"Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol. 1998;179:1359\u201375.","journal-title":"Am J Obstet Gynecol"},{"key":"1190_CR14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.4236\/wjcd.2014.45034","volume":"4","author":"B Landi","year":"2014","unstructured":"Landi B, Bezzeccheri V, Guerra B, Piemontese M, Cervi F, Cecchi L, et al. HIV infection in pregnancy and the risk of gestational hypertension and preeclampsia. World J Cardiovasc Dis. 2014;4:257.","journal-title":"World J Cardiovasc Dis"},{"key":"1190_CR15","doi-asserted-by":"publisher","first-page":"e0170063","DOI":"10.1371\/journal.pone.0170063","volume":"12","author":"NR Maharaj","year":"2017","unstructured":"Maharaj NR, Phulukdaree A, Nagiah S, Ramkaran P, Tiloke C, Chuturgoon AA. Pro-inflammatory cytokine levels in HIV infected and uninfected pregnant women with and without preeclampsia. PLoS One. 2017;12:e0170063.","journal-title":"PLoS One"},{"key":"1190_CR16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.5830\/CVJA-2012-078","volume":"24","author":"V Kalumba","year":"2013","unstructured":"Kalumba V, Moodley J, Naidoo T. Is the prevalence of pre-eclampsia affected by HIV\/AIDS? A retrospective case-control study: cardiovascular topics. Cardiovasc J Afr. 2013;24:24\u20137.","journal-title":"Cardiovasc J Afr"},{"key":"1190_CR17","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/ijgo.12038","volume":"136","author":"HM Sebitloane","year":"2017","unstructured":"Sebitloane HM, Moodley J, Sartorius B. Associations between HIV, highly active anti-retroviral therapy, and hypertensive disorders of pregnancy among maternal deaths in South Africa 2011\u20132013. Int J Gynecol Obstet. 2017;136:195\u20139.","journal-title":"Int J Gynecol Obstet"},{"key":"1190_CR18","doi-asserted-by":"publisher","first-page":"e1000229","DOI":"10.1371\/journal.pmed.1000229","volume":"7","author":"L Myer","year":"2010","unstructured":"Myer L, Carter RJ, Katyal M, Toro P, El-Sadr WM, Abrams EJ. Impact of antiretroviral therapy on incidence of pregnancy among HIV-infected women in Sub-Saharan Africa: a cohort study. PLoS Med. 2010;7:e1000229.","journal-title":"PLoS Med"},{"key":"1190_CR19","unstructured":"Organization WH. Global summary of the AIDS epidemic 2014. H\u00e4mtad fr\u00e5n. http:\/\/www.who.int\/hiv\/data\/2012_epi_core_en.png (2013)."},{"key":"1190_CR20","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/cyto.b.20418","volume":"74","author":"E Ono","year":"2008","unstructured":"Ono E, dos Santos A, Machado DM, Succi RCdM, Amed AM, Salomao R, et al. Immunologic features of HIV-1-infected women on HAART at delivery. Cytom Part B: Clin Cytom. 2008;74:236\u201343.","journal-title":"Cytom Part B: Clin Cytom"},{"key":"1190_CR21","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3851\/IMP1613","volume":"15","author":"CL Townsend","year":"2010","unstructured":"Townsend CL, Tookey PA, Newell M-L, Cortina-Borja M. Antiretroviral therapy in pregnancy: balancing the risk of preterm delivery with prevention of mother-to-child HIV transmission. Antivir Ther. 2010;15:775.","journal-title":"Antivir Ther"},{"key":"1190_CR22","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/QAI.0000000000000686","volume":"70","author":"JL Browne","year":"2015","unstructured":"Browne JL, Schrier VJ, Grobbee DE, Peters SA, Klipstein-Grobusch K. HIV, antiretroviral therapy, and hypertensive disorders in pregnancy: a systematic review and meta-analysis. JAIDS J Acquir Immune Defic Syndr. 2015;70:91\u20138.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"1190_CR23","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1097\/AOG.0000000000001424","volume":"127","author":"M Sansone","year":"2016","unstructured":"Sansone M, Sarno L, Saccone G, Berghella V, Maruotti GM, Migliucci A, et al. Risk of preeclampsia in human immunodeficiency virus\u2013infected pregnant women. Obstet Gynecol. 2016;127:1027\u201332.","journal-title":"Obstet Gynecol"},{"key":"1190_CR24","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/00042560-199902010-00011","volume":"20","author":"P Stratton","year":"1999","unstructured":"Stratton P, Tuomala RE, Abboud R, Rodriguez E, Rich K, Pitt J, et al. Obstetric and newborn outcomes in a cohort of HIV-infected pregnant women: a report of the women and infants transmission study. J Acquir Immune Defic Syndr Hum Retrovirology. 1999;20:179\u201386.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirology"},{"key":"1190_CR25","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/S0140-6736(02)11195-0","volume":"360","author":"R Wimalasundera","year":"2002","unstructured":"Wimalasundera R, Larbalestier N, Smith J, De Ruiter A, Thom SM, Hughes A, et al. Pre-eclampsia, antiretroviral therapy, and immune reconstitution. The Lancet. 2002;360:1152\u20134.","journal-title":"The Lancet"},{"key":"1190_CR26","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1097\/01.aids.0000244201.11006.1c","volume":"20","author":"AP Kourtis","year":"2006","unstructured":"Kourtis AP, Bansil P, McPheeters M, Meikle SF, Posner SF, Jamieson DJ. Hospitalizations of pregnant HIV-infected women in the USA prior to and during the era of HAART, 1994\u20132003. AIDS. 2006;20:1823\u201331.","journal-title":"AIDS"},{"key":"1190_CR27","first-page":"315, e1e5","volume":"201","author":"S Haeri","year":"2009","unstructured":"Haeri S, Shauer M, Dale M, Leslie J, Baker AM, Saddlemire S, et al. Obstetric and newborn infant outcomes in human immunodeficiency virus-infected women who receive highly active antiretroviral therapy. Am J Obstet Gynecol. 2009;201:315, e1\u2013e5.","journal-title":"Am J Obstet Gynecol"},{"key":"1190_CR28","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/j.1471-0528.2006.01183.x","volume":"114","author":"K Boer","year":"2007","unstructured":"Boer K, Nellen J, Patel D, Timmermans S, Tempelman C, Wibaut M, et al. The AmRo study: pregnancy outcome in HIV-1-infected women under effective highly active antiretroviral therapy and a policy of vaginal delivery. BJOG: Int J Obstet Gynaecol. 2007;114:148\u201355.","journal-title":"BJOG: Int J Obstet Gynaecol"},{"key":"1190_CR29","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.ejogrb.2004.04.014","volume":"117","author":"R Mattar","year":"2004","unstructured":"Mattar R, Amed AM, Lindsey PC, Sass N, Daher S. Preeclampsia and HIV infection. Eur J Obstet Gynecol Reprod Biol. 2004;117:240\u20131.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1190_CR30","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S1701-2163(16)35156-8","volume":"34","author":"T Boyajian","year":"2012","unstructured":"Boyajian T, Shah PS, Murphy KE. Risk of preeclampsia in HIV-positive pregnant women receiving HAART: a matched cohort study. J Obstet Gynaecol Can. 2012;34:136\u201341.","journal-title":"J Obstet Gynaecol Can"},{"key":"1190_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0301-2115(03)00153-2","volume":"111","author":"EC Study","year":"2003","unstructured":"Study EC. Pregnancy-related changes in the longer-term management of HIV-infected women in Europe. Eur J Obstet Gynecol Reprod Biol. 2003;111:3\u20138.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1190_CR32","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/01.aids.0000198090.70325.bd","volume":"20","author":"A Suy","year":"2006","unstructured":"Suy A, Mart\u00ednez E, Coll O, Lonca M, Palacio M, de Lazzari E, et al. Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy. AIDS. 2006;20:59\u201366.","journal-title":"AIDS"},{"key":"1190_CR33","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/jhh.2009.45","volume":"24","author":"L Poon","year":"2010","unstructured":"Poon L, Kametas N, Chelemen T, Leal A, Nicolaides K. Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach. J Hum Hypertens. 2010;24:104.","journal-title":"J Hum Hypertens"},{"key":"1190_CR34","unstructured":"Health Do. National antenatal sentinel HIV and syphilis prevalence survey in South Africa. Department of Health Pretoria; 2011."},{"key":"1190_CR35","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1080\/10641955.2016.1193190","volume":"35","author":"J Moodley","year":"2016","unstructured":"Moodley J, Onyangunga O, Maharaj N. Hypertensive disorders in primigravid black South African women: a one-year descriptive analysis. Hypertens Pregnancy. 2016;35:529\u201335.","journal-title":"Hypertens Pregnancy"},{"key":"1190_CR36","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S0140-6736(03)12359-8","volume":"361","author":"AR Mawson","year":"2003","unstructured":"Mawson AR. Effects of antiretroviral therapy on occurrence of pre-eclampsia. The Lancet. 2003;361:347\u20138.","journal-title":"The Lancet"},{"key":"1190_CR37","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/0143-4004(91)90339-H","volume":"12","author":"C Redman","year":"1991","unstructured":"Redman C. Pre-eclampsia and the placenta. Placenta. 1991;12:301\u20138.","journal-title":"Placenta"},{"key":"1190_CR38","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.bpobgyn.2011.01.005","volume":"25","author":"G Eastabrook","year":"2011","unstructured":"Eastabrook G, Brown M, Sargent I. The origins and end-organ consequence of pre-eclampsia. Best Pract Res Clin Obstet Gynaecol. 2011;25:435\u201347.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"1190_CR39","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/apha.12106","volume":"208","author":"AC Palei","year":"2013","unstructured":"Palei AC, Spradley FT, Warrington JP, George EM, Granger JP. Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiology. Acta Physiol. 2013;208:224\u201333.","journal-title":"Acta Physiol"},{"key":"1190_CR40","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S0140-6736(15)00070-7","volume":"387","author":"BW Mol","year":"2016","unstructured":"Mol BW, Roberts CT, Thangaratinam S, Magee LA, De Groot CJ, Hofmeyr GJ. Pre-eclampsia. The Lancet. 2016;387:999\u20131011.","journal-title":"The Lancet"},{"key":"1190_CR41","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jri.2005.10.004","volume":"69","author":"A Ishitani","year":"2006","unstructured":"Ishitani A, Sageshima N, Hatake K. The involvement of HLA-E and-F in pregnancy. J Reprod Immunol. 2006;69:101\u201313.","journal-title":"J Reprod Immunol"},{"key":"1190_CR42","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/humupd\/dmi048","volume":"12","author":"TVF Hviid","year":"2005","unstructured":"Hviid TVF. HLA-G in human reproduction: aspects of genetics, function and pregnancy complications. Hum Reprod Updat. 2005;12:209\u201332.","journal-title":"Hum Reprod Updat"},{"key":"1190_CR43","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/S1472-6483(10)60659-1","volume":"13","author":"IL Sargent","year":"2006","unstructured":"Sargent IL, Borzychowski AM, Redman CW. Immunoregulation in normal pregnancy and pre-eclampsia: an overview. Reprod Biomed Online. 2006;13:680\u20136.","journal-title":"Reprod Biomed Online"},{"key":"1190_CR44","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.placenta.2006.01.009","volume":"27","author":"J Tabiasco","year":"2006","unstructured":"Tabiasco J, Rabot M, Aguerre-Girr M, El Costa H, Berrebi A, Parant O, et al. Human decidual NK cells: unique phenotype and functional properties\u2014a review. Placenta. 2006;27:34\u20139.","journal-title":"Placenta"},{"key":"1190_CR45","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1600-0897.2010.00913.x","volume":"65","author":"H Ahn","year":"2011","unstructured":"Ahn H, Park J, Gilman-Sachs A, Kwak-Kim J. Immunologic characteristics of preeclampsia, a comprehensive review. Am J Reprod Immunol. 2011;65:377\u201394.","journal-title":"Am J Reprod Immunol"},{"key":"1190_CR46","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1093\/molehr\/6.1.88","volume":"6","author":"D Goldman-Wohl","year":"2000","unstructured":"Goldman-Wohl D, Ariel I, Greenfield C, Hochner-Celnikier D, Cross J, Fisher S, et al. Lack of human leukocyte antigen-G expression in extravillous trophoblasts is associated with pre-eclampsia. Mol Hum Reprod. 2000;6:88\u201395.","journal-title":"Mol Hum Reprod"},{"key":"1190_CR47","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1600-0897.1996.tb00185.x","volume":"36","author":"N Hara","year":"1996","unstructured":"Hara N, Fujii T, Yamashita T, Kozuma S, Okai T, Taketani Y. Altered expression of human leukocyte antigen G (HLA-G) on extravillous trophoblasts in preeclampsia: immunohistological demonstration with anti-HLA-G specific antibody \u201c87G\u201d and anti-cytokeratin antibody \u201cCAM5. 2\u201d. Am J Reprod Immunol. 1996;36:349\u201358.","journal-title":"Am J Reprod Immunol"},{"key":"1190_CR48","doi-asserted-by":"publisher","first-page":"14873","DOI":"10.4172\/2167-1095.1000116","volume":"2","author":"S Novotny","year":"2013","unstructured":"Novotny S, Wallace K, Herse F, Moseley J, Darby M, Heath J, et al. CD4+ T cells play a critical role in mediating hypertension in response to placental ischemia. J Hypertens. 2013;2:14873. https:\/\/doi.org\/10.4172\/2167-1095.1000116 .","journal-title":"J Hypertens."},{"key":"1190_CR49","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/S0198-8859(00)00197-X","volume":"61","author":"P Paul","year":"2000","unstructured":"Paul P, Cabestre FA, Lefebvre S, Khalil-Daher I, Vazeux G, Quiles RMM, et al. Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5,-G6, and-G7 transcripts in human transfected cells. Hum Immunol. 2000;61:1138\u201349.","journal-title":"Hum Immunol"},{"key":"1190_CR50","first-page":"524954","volume":"94","author":"N Rouas-Freiss","year":"1997","unstructured":"Rouas-Freiss N, Marchal RE, Kirszenbaum M, Dausset J, Carosella ED. The \u03b11 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors? Proc Nat Acad Sci. 1997;94:5249\u201354.","journal-title":"Proc Nat Acad Sci"},{"key":"1190_CR51","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1093\/humupd\/dmr043","volume":"18","author":"M Dahl","year":"2011","unstructured":"Dahl M, Hviid TVF. Human leucocyte antigen class Ib molecules in pregnancy success and early pregnancy loss. Hum Reprod Update. 2011;18:92\u2013109.","journal-title":"Hum Reprod Update"},{"key":"1190_CR52","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1093\/intimm\/11.5.803","volume":"11","author":"P Moreau","year":"1999","unstructured":"Moreau P, Adrian-Cabestre F, Menier C, Guiard V, Gourand L, Dausset J, et al. IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. Int Immunol. 1999;11:803\u201311.","journal-title":"Int Immunol"},{"key":"1190_CR53","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.humimm.2003.08.353","volume":"64","author":"A Cabello","year":"2003","unstructured":"Cabello A, Rivero A, Garcia MJ, Lozano JM, Torre-Cisneros J, Gonz\u00e1lez R, et al. HAART induces the expression of HLA-G on peripheral monocytes in HIV-1 infected individuals. Hum Immunol. 2003;64:1045\u20139.","journal-title":"Hum Immunol"},{"key":"1190_CR54","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/00002030-200202150-00005","volume":"16","author":"JM Lozano","year":"2002","unstructured":"Lozano JM, Gonz\u00e1lez R, Kindel\u00e1n JM, Rouas-Freiss N, Caballos R, Dausset J, et al. Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule. AIDS. 2002;16:347\u201351.","journal-title":"AIDS"},{"key":"1190_CR55","doi-asserted-by":"publisher","first-page":"6426","DOI":"10.4049\/jimmunol.164.12.6426","volume":"164","author":"M Onno","year":"2000","unstructured":"Onno M, Pangault C, Le Friec G, Guilloux V, Andr\u00e9 P, Fauchet R. Modulation of HLA-G antigens expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection. J Immunol. 2000;164:6426\u201334.","journal-title":"J Immunol"},{"key":"1190_CR56","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1099\/vir.0.79867-0","volume":"85","author":"M Derrien","year":"2004","unstructured":"Derrien M, Pizzato N, Dolcini G, Menu E, Chaouat G, Lenfant F, et al. Human immunodeficiency virus 1 downregulates cell surface expression of the non-classical major histocompatibility class I molecule HLA-G1. J Gen Virol. 2004;85:1945\u201354.","journal-title":"J Gen Virol"},{"key":"1190_CR57","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1099\/vir.0.18735-0","volume":"84","author":"F Lenfant","year":"2003","unstructured":"Lenfant F, Pizzato N, Liang S, Davrinche C, Le Bouteiller P, Horuzsko A. Induction of HLA-G-restricted human cytomegalovirus pp65 (UL83)-specific cytotoxic T lymphocytes in HLA-G transgenic mice. J Gen Virol. 2003;84:307\u201317.","journal-title":"J Gen Virol"},{"key":"1190_CR58","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2249.2006.03268.x","volume":"147","author":"L Donaghy","year":"2007","unstructured":"Donaghy L, Gros F, Amiot L, Mary C, Maillard A, Guiguen C, et al. Elevated levels of soluble non-classical major histocompatibility class I molecule human leucocyte antigen (HLA)-G in the blood of HIV-infected patients with or without visceral leishmaniasis. Clin Exp Immunol. 2007;147:236\u201340.","journal-title":"Clin Exp Immunol"},{"key":"1190_CR59","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.clim.2009.08.002","volume":"133","author":"G Murdaca","year":"2009","unstructured":"Murdaca G, Contini P, Setti M, Cagnati P, Lantieri F, Indiveri F, et al. Behavior of non-classical soluble HLA class G antigens in human immunodeficiency virus 1-infected patients before and after HAART: comparison with classical soluble HLA-A,-B,-C antigens and potential role in immune-reconstitution. Clin Immunol. 2009;133:238\u201344.","journal-title":"Clin Immunol"},{"key":"1190_CR60","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/ni1037","volume":"5","author":"VR Aluvihare","year":"2004","unstructured":"Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol. 2004;5:266.","journal-title":"Nat Immunol"},{"key":"1190_CR61","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jri.2005.01.003","volume":"65","author":"AC Zenclussen","year":"2005","unstructured":"Zenclussen AC. CD4 + CD25 + T regulatory cells in murine pregnancy. J Reprod Immunol. 2005;65:101\u201310.","journal-title":"J Reprod Immunol"},{"key":"1190_CR62","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/j.1600-0897.2010.00836.x","volume":"63","author":"G Mor","year":"2010","unstructured":"Mor G, Cardenas I. The immune system in pregnancy: a unique complexity. Am J Reprod Immunol. 2010;63:425\u201333.","journal-title":"Am J Reprod Immunol"},{"key":"1190_CR63","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/aji.12289","volume":"72","author":"K Racicot","year":"2014","unstructured":"Racicot K, Kwon JY, Aldo P, Silasi M, Mor G. Understanding the complexity of the immune system during pregnancy. Am J Reprod Immunol. 2014;72:107\u201316.","journal-title":"Am J Reprod Immunol"},{"key":"1190_CR64","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1051\/rnd:19881006","volume":"28","author":"JN Bulmer","year":"1988","unstructured":"Bulmer JN, Denise P, Ritson A. Immunoregulatory cells in human decidua: morphology, immunohistochemistry and function. Reprod Nutr D\u00e9v. 1988;28:1599\u2013614.","journal-title":"Reprod Nutr D\u00e9v"},{"key":"1190_CR65","first-page":"149","volume-title":"Macrophage-trophoblast interactions","author":"G Mor","year":"2006","unstructured":"Mor G, Straszewski-Chavez SL, Abrahams VM. Macrophage-trophoblast interactions. Placenta: Springer; 2006. pp.\u00a0149\u201363."},{"key":"1190_CR66","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1093\/humupd\/4.5.480","volume":"4","author":"A King","year":"1998","unstructured":"King A, Burrows T, Verma S, Hiby S, Loke Y. Human uterine lymphocytes. Hum Reprod Update. 1998;4:480\u20135.","journal-title":"Hum Reprod Update"},{"key":"1190_CR67","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s12026-015-8664-y","volume":"62","author":"LS Angelo","year":"2015","unstructured":"Angelo LS, Banerjee PP, Monaco-Shawver L, Rosen JB, Makedonas G, Forbes LR, et al. Practical NK cell phenotyping and variability in healthy adults. Immunol Res. 2015;62:341\u201356.","journal-title":"Immunol Res"},{"key":"1190_CR68","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/aji.12259","volume":"72","author":"E Giuliani","year":"2014","unstructured":"Giuliani E, Parkin KL, Lessey BA, Young SL, Fazleabas AT. Characterization of uterine NK cells in women with infertility or recurrent pregnancy loss and associated endometriosis. Am J Reprod Immunol. 2014;72:262\u20139.","journal-title":"Am J Reprod Immunol"},{"key":"1190_CR69","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.placenta.2009.12.022","volume":"31","author":"G Lash","year":"2010","unstructured":"Lash G, Robson S, Bulmer J. Functional role of uterine natural killer (uNK) cells in human early pregnancy decidua. Placenta. 2010;31:87\u201392.","journal-title":"Placenta"},{"key":"1190_CR70","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nri886","volume":"2","author":"A Moffett-King","year":"2002","unstructured":"Moffett-King A. Natural killer cells and pregnancy. Nat Rev Immunol. 2002;2:656\u201363.","journal-title":"Nat Rev Immunol"},{"key":"1190_CR71","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/nm1452","volume":"12","author":"J Hanna","year":"2006","unstructured":"Hanna J, Goldman-Wohl D, Hamani Y, Avraham I, Greenfield C, Natanson-Yaron S, et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med. 2006;12:1065.","journal-title":"Nat Med"},{"key":"1190_CR72","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.hemonc.2014.11.006","volume":"8","author":"A Mandal","year":"2015","unstructured":"Mandal A, Viswanathan C. Natural killer cells: in health and disease. Hematol\/Oncol Stem Cell Ther. 2015;8:47\u201355.","journal-title":"Hematol\/Oncol Stem Cell Ther"},{"key":"1190_CR73","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1002\/1521-4141(200006)30:6<1623::AID-IMMU1623>3.0.CO;2-M","volume":"30","author":"A King","year":"2000","unstructured":"King A, Allan DS, Bowen M, Powis SJ, Joseph S, Verma S, et al. HLA-E is expressed on trophoblast and interacts with CD94\/NKG2 receptors on decidual NK cells. Eur J Immunol. 2000;30:1623\u201331.","journal-title":"Eur J Immunol"},{"key":"1190_CR74","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0065-230X(03)90004-2","volume":"90","author":"J Wu","year":"2003","unstructured":"Wu J, Lanier LL. Natural killer cells and cancer. Adv Cancer Res. 2003;90:127\u201356.","journal-title":"Adv Cancer Res"},{"key":"1190_CR75","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/35095564","volume":"1","author":"A Cerwenka","year":"2001","unstructured":"Cerwenka A, Lanier LL. Natural killer cells, viruses and cancer. Nat Rev Immunol. 2001;1:41\u20139.","journal-title":"Nat Rev Immunol"},{"key":"1190_CR76","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1600-0897.2009.00724.x","volume":"62","author":"N Bachmayer","year":"2009","unstructured":"Bachmayer N, Sohlberg E, Sundstr\u00f6m Y, Hamad RR, Berg L, Bremme K, et al. Women with pre-eclampsia have an altered NKG2A and NKG2C receptor expression on peripheral blood natural killer cells. Am J Reprod Immunol. 2009;62:147\u201357.","journal-title":"Am J Reprod Immunol"},{"key":"1190_CR77","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1365-2567.2008.03027.x","volume":"126","author":"A Poli","year":"2009","unstructured":"Poli A, Michel T, Th\u00e9r\u00e9sine M, Andres E, Hentges F, Zimmer J. CD56bright natural killer (NK) cells: an important NK cell subset. Immunology. 2009;126:458\u201365.","journal-title":"Immunology"},{"key":"1190_CR78","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","volume":"22","author":"MA Cooper","year":"2001","unstructured":"Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol. 2001;22:633\u201340.","journal-title":"Trends Immunol"},{"key":"1190_CR79","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.4049\/jimmunol.172.3.1455","volume":"172","author":"G Ferlazzo","year":"2004","unstructured":"Ferlazzo G, Thomas D, Lin S-L, Goodman K, Morandi B, Muller WA, et al. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J Immunol. 2004;172:1455\u201362.","journal-title":"J Immunol"},{"key":"1190_CR80","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1038\/ni1138","volume":"5","author":"A Mart\u00edn-Fontecha","year":"2004","unstructured":"Mart\u00edn-Fontecha A, Thomsen LL, Brett S, Gerard C, Lipp M, Lanzavecchia A, et al. Induced recruitment of NK cells to lymph nodes provides IFN-\u03b3 for T H 1 priming. Nat Immunol. 2004;5:1260.","journal-title":"Nat Immunol"},{"key":"1190_CR81","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/S1074-7613(03)00264-4","volume":"19","author":"R Mocikat","year":"2003","unstructured":"Mocikat R, Braum\u00fcller H, Gumy A, Egeter O, Ziegler H, Reusch U, et al. Natural killer cells activated by MHC class I low targets prime dendritic cells to induce protective CD8 T cell responses. Immunity. 2003;19:561\u20139.","journal-title":"Immunity"},{"key":"1190_CR82","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1086\/509811","volume":"195","author":"CM Mela","year":"2007","unstructured":"Mela CM, Goodier MR. The contribution of cytomegalovirus to changes in NK cell receptor expression in HIV-1-infected individuals. J Infect Dis. 2007;195:158\u20139.","journal-title":"J Infect Dis"},{"key":"1190_CR83","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ajog.2007.07.040","volume":"198","author":"A Conde-Agudelo","year":"2008","unstructured":"Conde-Agudelo A, Villar J, Lindheimer M. Maternal infection and risk of preeclampsia: systematic review and metaanalysis. Am J Obstet Gynecol. 2008;198:7\u201322.","journal-title":"Am J Obstet Gynecol"},{"key":"1190_CR84","first-page":"1219","volume":"41","author":"S Kottilil","year":"2003","unstructured":"Kottilil S. Natural killer cells in HIV-1 infection: role of NK cell-mediated non-cytolytic mechanisms in pathogenesis of HIV-1 infection. Indian J Exp Biol. 2003;41:1219\u201325.","journal-title":"Indian J Exp Biol"},{"key":"1190_CR85","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1093\/humupd\/dmq007","volume":"16","author":"E Laresgoiti-Servitje","year":"2010","unstructured":"Laresgoiti-Servitje E, G\u00f3mez-L\u00f3pez N, Olson DM. An immunological insight into the origins of pre-eclampsia. Hum Reprod Update. 2010;16:510\u201324.","journal-title":"Hum Reprod Update"},{"key":"1190_CR86","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/0167-5699(93)90235-D","volume":"14","author":"TG Wegmann","year":"1993","unstructured":"Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today. 1993;14:353\u20136.","journal-title":"Immunol Today"},{"key":"1190_CR87","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jri.2006.06.005","volume":"73","author":"W Hu","year":"2007","unstructured":"Hu W, Wang H, Wang Z, Huang H, Dong M. Elevated serum levels of interleukin-15 and interleukin-16 in preeclampsia. J Reprod Immunol. 2007;73:166\u201371.","journal-title":"J Reprod Immunol"},{"key":"1190_CR88","doi-asserted-by":"publisher","first-page":"4","DOI":"10.5144\/0256-4947.2000.4","volume":"20","author":"SO Olusi","year":"2000","unstructured":"Olusi SO, Diejomaoh M, Omu A, Abdulaziz A, Prabha K, George S. Interleukins in preeclampsia. Ann Saudi Med. 2000;20:4\u20137.","journal-title":"Ann Saudi Med"},{"key":"1190_CR89","first-page":"73","volume":"43","author":"TR Adri\u00e1n","year":"2002","unstructured":"Adri\u00e1n TR, Ruiz A, V\u00edlchez RM, Est\u00e9vez J, Atencio R. Interleukin-2 receptor serum concentrations in normal pregnancy and pre-eclampsia. Investig Clin. 2002;43:73\u201378.","journal-title":"Investig Clin"},{"key":"1190_CR90","first-page":"937","volume":"84","author":"IA Greer","year":"1994","unstructured":"Greer IA, Lyall F, Perera T, Boswell F, Macara LM. Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction? Obstet Gynecol. 1994;84:937\u201340.","journal-title":"Obstet Gynecol"},{"key":"1190_CR91","doi-asserted-by":"publisher","first-page":"213","DOI":"10.15448\/1980-6108.2013.4.14862","volume":"23","author":"MR Hentschke","year":"2014","unstructured":"Hentschke MR, Lucas LS, Krauspenhar B, Felix RP, Sussela AO, Berlesi F, et al. Increased levels of the soluble receptor of Interleukin-6 in patients with preeclampsia compared to normotensive pregnant women. Sci Medica. 2014;23:213\u20138.","journal-title":"Sci Medica"},{"key":"1190_CR92","unstructured":"Udenze I, Amadi C, Awolola N, Makwe CC. The role of cytokines as inflammatory mediators in preeclampsia. Pan Afr Med J. 2015;20(1)."},{"key":"1190_CR93","first-page":"1707","volume":"16","author":"A Ozler","year":"2012","unstructured":"Ozler A, Turgut A, Sak M, Evsen M, Soydinc H, Evliyaoglu O, et al. Serum levels of neopterin, tumor necrosis factor-alpha and Interleukin-6 in preeclampsia: relationship with disease severity. Eur Rev Med Pharmacol Sci. 2012;16:1707\u201312.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1190_CR94","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jsgi.2005.02.005","volume":"12","author":"L Arriaga-Pizano","year":"2005","unstructured":"Arriaga-Pizano L, Jimenez-Zamudio L, Vadillo-Ortega F, Martinez-Flores A, Herrerias-Canedo T, Hernandez-Guerrero C. The predominant Th1 cytokine profile in maternal plasma of preeclamptic women is not reflected in the choriodecidual and fetal compartments. J Soc Gynecol Investig. 2005;12:335\u201342.","journal-title":"J Soc Gynecol Investig"},{"key":"1190_CR95","first-page":"179","volume":"4","author":"R Mansouri","year":"2007","unstructured":"Mansouri R, Akbari F, Vodjgani M, Mahboudi F, Kalantar F, Mirahmadian M. Serum cytokines profiles in Iranian patients with preeclampsia. Iran J Immunol. 2007;4:179\u201385.","journal-title":"Iran J Immunol"},{"key":"1190_CR96","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/1477-7827-9-124","volume":"9","author":"A Molvarec","year":"2011","unstructured":"Molvarec A, Szarka A, Walentin S, Bek\u0151 G, Kar\u00e1di I, Proh\u00e1szka Z, et al. Serum leptin levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in normal pregnancy and preeclampsia. Reprod Biol Endocrinol. 2011;9:124.","journal-title":"Reprod Biol Endocrinol"},{"key":"1190_CR97","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1471-2172-11-59","volume":"11","author":"A Szarka","year":"2010","unstructured":"Szarka A, Rig\u00f3 J, L\u00e1z\u00e1r L, Bek\u0151 G, Molvarec A. Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array. BMC Immunol. 2010;11:59.","journal-title":"BMC Immunol"},{"key":"1190_CR98","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/j.1600-0897.1998.tb00398.x","volume":"40","author":"KP Conrad","year":"1998","unstructured":"Conrad KP, Miles TM, Benyo DF. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol. 1998;40:102\u201311.","journal-title":"Am J Reprod Immunol"},{"key":"1190_CR99","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.4049\/jimmunol.163.6.3491","volume":"163","author":"A Hennessy","year":"1999","unstructured":"Hennessy A, Pilmore H, Simmons L, Painter D. A deficiency of placental IL-10 in preeclampsia. J Immunol. 1999;163:3491\u20135.","journal-title":"J Immunol"},{"key":"1190_CR100","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.placenta.2005.05.003","volume":"27","author":"A Makris","year":"2006","unstructured":"Makris A, Xu B, Yu B, Thornton C, Hennessy A. Placental deficiency of interleukin-10 (IL-10) in preeclampsia and its relationship to an IL10 promoter polymorphism. Placenta. 2006;27:445\u201351.","journal-title":"Placenta"},{"key":"1190_CR101","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1600-0897.2007.00486.x","volume":"58","author":"A Sharma","year":"2007","unstructured":"Sharma A, Satyam A, Sharma JB. Leptin, IL-10 and inflammatory markers (TNF-\u03b1, IL-6 and IL-8) in pre-eclamptic, normotensive pregnant and healthy non-pregnant women. Am J Reprod Immunol. 2007;58:21\u201330.","journal-title":"Am J Reprod Immunol"},{"key":"1190_CR102","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1600-0897.2007.00491.x","volume":"58","author":"B Borekci","year":"2007","unstructured":"Borekci B, Aksoy H, Al RA, Demircan B, Kadanali S. Maternal serum interleukin-10, interleukin-2 and interleukin-6 in pre-eclampsia and eclampsia. Am J Reprod Immunol. 2007;58:56\u201364.","journal-title":"Am J Reprod Immunol"},{"key":"1190_CR103","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.4049\/jimmunol.154.9.4261","volume":"154","author":"G Chaouat","year":"1995","unstructured":"Chaouat G, Meliani AA, Martal J, Raghupathy R, Elliott J, Elliot J, et al. IL-10 prevents naturally occurring fetal loss in the CBA x DBA\/2 mating combination, and local defect in IL-10 production in this abortion-prone combination is corrected by in vivo injection of IFN-tau. J Immunol. 1995;154:4261\u20138.","journal-title":"J Immunol"},{"key":"1190_CR104","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1095\/biolreprod66.6.1853","volume":"66","author":"S Aschkenazi","year":"2002","unstructured":"Aschkenazi S, Straszewski S, Verwer KM, Foellmer H, Rutherford T, Mor G. Differential regulation and function of the Fas\/Fas ligand system in human trophoblast cells. Biol Reprod. 2002;66:1853\u201361.","journal-title":"Biol Reprod"},{"key":"1190_CR105","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cyto.2004.10.011","volume":"29","author":"S Orange","year":"2005","unstructured":"Orange S, Rasko JE, Thompson JF, Vaughan J, Olive E, Pedler M, et al. Interleukin-10 regulates arterial pressure in early primate pregnancy. Cytokine. 2005;29:176\u201385.","journal-title":"Cytokine"},{"key":"1190_CR106","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0020-7292(01)00499-4","volume":"75","author":"E Teran","year":"2001","unstructured":"Teran E, Escudero C, Moya W, Flores M, Vallance P, Lopez-Jaramillo P. Elevated C-reactive protein and pro-inflammatory cytokines in Andean women with pre-eclampsia. Int J Gynecol Obstet. 2001;75:243\u20139.","journal-title":"Int J Gynecol Obstet"},{"key":"1190_CR107","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0301-2115(99)00065-2","volume":"86","author":"D Darmochwal-Kolarz","year":"1999","unstructured":"Darmochwal-Kolarz D, Leszczynska-Gorzelak B, Rolinski J, Oleszczuk J. T helper 1-and T helper 2-type cytokine imbalance in pregnant women with pre-eclampsia. Eur J Obstet Gynecol Reprod Biol. 1999;86:165\u201370.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1190_CR108","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S0301-2115(02)00350-0","volume":"109","author":"JR Wilczy\u0144ski","year":"2003","unstructured":"Wilczy\u0144ski JR, Tch\u00f3rzewski H, Banasik M, G\u0142owacka E, Wieczorek A, Lewkowicz P, et al. Lymphocyte subset distribution and cytokine secretion in third trimester decidua in normal pregnancy and preeclampsia. Eur J Obstet Gynecol Reprod Biol. 2003;109:8\u201315.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1190_CR109","doi-asserted-by":"publisher","first-page":"R353R8","DOI":"10.1152\/ajpregu.00051.2012","volume":"303","author":"P Dhillion","year":"2012","unstructured":"Dhillion P, Wallace K, Herse F, Scott J, Wallukat G, Heath J, et al. IL-17-mediated oxidative stress is an important stimulator of AT1-AA and hypertension during pregnancy. Am J Physiol-Regul Integr Comp Physiol. 2012;303:R353\u2013R8.","journal-title":"Am J Physiol-Regul Integr Comp Physiol"},{"key":"1190_CR110","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1600-0897.2011.00987.x","volume":"66","author":"G Toldi","year":"2011","unstructured":"Toldi G, Rig\u00f3 J, Stenczer B, V\u00e1s\u00e1rhelyi B, Molvarec A. Increased prevalence of IL-17-producing peripheral blood lymphocytes in pre-eclampsia. Am J Reprod Immunol. 2011;66:223\u20139.","journal-title":"Am J Reprod Immunol"},{"key":"1190_CR111","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1161\/HYPERTENSIONAHA.113.01514","volume":"62","author":"DC Cornelius","year":"2013","unstructured":"Cornelius DC, Hogg JP, Scott J, Wallace K, Herse F, Moseley J, et al. Administration of interleukin-17 soluble receptor C suppresses TH17 cells, oxidative stress, and hypertension in response to placental ischemia during Pregnancy novelty and significance. Hypertension. 2013;62:1068\u201373.","journal-title":"Hypertension"},{"key":"1190_CR112","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1161\/HYPERTENSIONAHA.110.168344","volume":"57","author":"K Wallace","year":"2011","unstructured":"Wallace K, Richards S, Dhillon P, Weimer A, Edholm E-s, Bengten E, et al. CD4 + T-helper cells stimulated in response to placental ischemia mediate hypertension during pregnancy. Hypertension. 2011;57:949\u201355.","journal-title":"Hypertension"},{"key":"1190_CR113","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jri.2005.12.001","volume":"70","author":"S Fiore","year":"2006","unstructured":"Fiore S, Newell M-L, Trabattoni D, Thorne C, Gray L, Savasi V, et al. Antiretroviral therapy-associated modulation of Th1 and Th2 immune responses in HIV-infected pregnant women. J Reprod Immunol. 2006;70:143\u201350.","journal-title":"J Reprod Immunol"},{"key":"1190_CR114","first-page":"647","volume":"11","author":"R Alonso","year":"2000","unstructured":"Alonso R, Resino S, Bell\u00f3n J, Mu\u00f1oz-Fern\u00e1ndez M. Antiretroviral treatment induces a shift to type-2 cytokine responses in HIV-1 infected pregnant women. Eur Cytokine Netw. 2000;11:647\u201353.","journal-title":"Eur Cytokine Netw"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00011-018-1190-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-018-1190-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-018-1190-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T10:46:23Z","timestamp":1693910783000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00011-018-1190-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,1]]},"references-count":114,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["1190"],"URL":"https:\/\/doi.org\/10.1007\/s00011-018-1190-3","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.734167249.793555616","asserted-by":"object"}]},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,1]]},"assertion":[{"value":"22 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}